RCM
DMTX

RA Capital Management’s Dimension Therapeutics, Inc DMTX Stock Holding History

RA Capital Management’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-928,199
Closed -$4.04M – 32
2016
Q4 		$4.04M Sell
928,199
-619,834
-40% -$3.3M 0.57% 23
2016
Q3 		$12.4M Hold
1,548,033
– – 1.28% 20
2016
Q2 		$9.29M Hold
1,548,033
– – 1.29% 18
2016
Q1 		$12.1M Buy
1,548,033
+460,103
+42% +$3.62M 1.55% 22
2015
Q4 		$12.3M Buy
+1,087,930
New +$13.8M 1.21% 24

Other funds holding DMTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

RA Capital Management's DMTX Position: Q1 2017 in Review

RA Capital Management sold out of Dimension Therapeutics, Inc (DMTX) in Q1 2017, closing a stake of 928,199 shares — an estimated $4.04M sold.

RA Capital Management first reported a position in DMTX in Q4 2015 and held it in 5 quarters. The position peaked at $12.4M in Q3 2016. 47 funds tracked by Wall St. Rank hold DMTX as of Q1 2017.

  • RA Capital Management reported no remaining Dimension Therapeutics, Inc position as of Q1 2017 after selling out during the quarter.
  • RA Capital Management sold 928,199 Dimension Therapeutics, Inc shares in Q1 2017, an estimated $4.04M.
  • RA Capital Management first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 5 quarters.
  • RA Capital Management's Dimension Therapeutics, Inc position peaked at $12.4M in Q3 2016.
  • 47 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q1 2017.

Based on RA Capital Management's 13F filing for Q1 2017, filed 15 May 2017.